Chronic hepatitis C in Austria, 1992-2006: Genotype distribution and demographic factors

Eurosurveillance

Volumn 15, Issue 8, 2010, Pages 1-7

  Maieron, A ^a   Metz Gercek, S ^a   Hackl, F ^b   Luger, C ^a   Ziachehabi, A ^a   Strauss, R ^c   Schofl R ^a   Mittermayer, H ^a  

^a ELISABETHINEN HOSPITAL   (Austria)

^b Diakonissen Hospital Linz   (Austria)

^c Federal Ministry of Health and Women   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRIA; BODY MASS; DEMOGRAPHY; FEMALE; GENOTYPE; GENOTYPING TECHNIQUE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; POLYMERASE CHAIN REACTION; RISK FACTOR; VIRUS TRANSMISSION; DNA FINGERPRINTING; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GEOGRAPHY; HEPATITIS C VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY;

ADULT; AUSTRIA; DEMOGRAPHY; DNA FINGERPRINTING; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GEOGRAPHY; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED;

EID: 77952523797     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.15.08.19492-en     Document Type: Article

References (41)

1. Alberti A, Vario A, Ferrari A, Pistis R. Review article: chronic hepatitis C--natural history and cofactors. Aliment Pharmacol Ther. 2005;22 Suppl 2:74-8.
2. Negro F, Clement S. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C. J Viral Hepat. 2009;16(10):681-8.
3. World Health Organization (WHO). Hepatitis C. Weekly Epidemiological Record: Geneva, WHO 1997. p. 65-9.
4. World Health Organization (WHO). [Internet] Hepatitis C. Fact sheet No 164: Geneva, WHO 1997. Available from: http://www.who.int/inf-fs/en/fact164.html.
5. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14(1):1-21, vii.
6. Strader DB, Wright T, Thomas DL, Seeff LB; American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147-71.
7. Ramarokoto CE, Rakotomanana F, Ratsitorahina M, Raharimanga V, Razafindratsimandresy R, Randremanana R, et al. Seroprevalence of hepatitis C and associated risk factors in urban areas of Antananarivo, Madagascar. BMC Infect Dis. 2008;8:25.
8. World Health Organization (WHO). [Internet] Hepatitis C. Fact sheet No 164: Geneva, WHO 2000. Available from: http://www.who.int/inf-fs/en/fact164.html
9. EASL International Consensus Conference on hepatitis C. Paris, 26-27 February 1999. Consensus statement. J Hepatol. 1999;31 Suppl 1:3-8.
10. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705-14.
11. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. J Hepatol. 2001;34(5):730-9.
12. Strauss R, Fulop G, Pfeifer C. Hepatitis C in Austria 1993-2000: reporting bias distort HCV epidemiology in Austria. Euro Surveill. 2003;8(5):113-8. pii=412. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=412.
13. Nolte FS, Thurmond C, Fried MW. Preclinical evaluation of AMPLICOR hepatitis C virus test for detection of hepatitis C virus RNA. J Clin Microbiol. 1995;33(7):1775-8.
14. Kessler HH, Dragon EA, Pierer K, Santner BI, Liao Y, Stunzner D, et al. Performance of the automated COBAS AMPLICOR system for the detection of hepatitis C virus RNA. Clin Diagn Virol. 1997;7(3):139-45.
15. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, et al. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol. 2007;38(4):326-33.
16. Gerken G, Rothaar T, Rumi MG, Soffredini R, Trippler M, Blunk MJ, et al. Performance of the COBAS AMPLICOR HCV MONITOR test, version 2.0, an automated reverse transcription-PCR quantitative system for hepatitis C virus load determination. J Clin Microbiol. 2000;38(6):2210-4.
17. Comanor L, Elkin C, Leung K, Krajden M, Kronquist K, Nicolas K, et al. Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay. J Clin Virol. 2003;28(1):14-26.
18. Le Pogam S, Dubois F, Christen R, Raby C, Cavicchini A, Goudeau A. Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping. J Clin Microbiol. 1998;36(5):1461-3.
19. van Doorn LJ, Kleter B, Pike I, Quint W. Analysis of hepatitis C virus isolates by serotyping and genotyping. J Clin Microbiol. 1996;34(7):1784-7.
20. Bevölkerung 2001 nach Geburtsland und Bundesländern. [Internet]. Vienna: Statistik Austria. Available from: http://www.statistik.at/web_de/static/bevoelkerung_2001_nach_geburtsland_und_bundeslaendern_022893.pdf. German.
21. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol. 2008;48(1):148-62.
22. Jahresausweise über angezeigte übertragbare Krankheiten ab 2000 [Annual records of reported communicable diseases from 2000 onwards]. Vienna: Bundesministerium für Gesundheit, Familie und Jugend. Available from: http://www.bmgfj.gv.at/cms/site/standard.html?channel=CH0745&doc=CMS1038921188383. German.
23. Haushofer AC, Kopty C, Hauer R, Brunner H, Halbmayer WM. HCV genotypes and age distribution in patients of Vienna and surrounding areas. J Clin Virol. 2001;20(1-2):41-7.
24. Goeser T, Tox U, Muller HM, Arnold JC, Theilmann L. [Significance of genotypes in chronic hepatitis C virus infection and hepatitis C virus induced liver cirrhosis in Germany]. Dtsch Med Wochenschr. 1995;120(31-32):1070-3. German.
25. Ross RS, Viazov S, Renzing-Kohler K, Roggendorf M. Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes. J Med Virol. 2000;60(2):122-5.
26. Huppe D, Zehnter E, Mauss S, Boker K, Lutz T, Racky S, et al. [Epidemiology of chronic hepatitis C in Germany--an analysis of 10,326 patients in hepatitis centres and outpatient units]. Z Gastroenterol. 2008;46(1):34-44. German.
27. Seme K, Poljak M, Lesnicar G, Brinovec V, Stepec S, Koren S. Distribution of hepatitis C virus genotypes in Slovenia. Scand J Infect Dis. 1997;29(1):29-31.
28. Cenci M, De Soccio G, Recchia O. Prevalence of hepatitis C virus (HCV) genotypes in central Italy. Anticancer Res. 2003;23(6D):5129-32.
29. Ray SC, Arthur RR, Carella A, Bukh J, Thomas DL. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis. 2000;182(3):698-707.
30. Arafa N, El Hoseiny M, Rekacewicz C, Bakr I, El-Kafrawy S, El Daly M, et al. Changing pattern of hepatitis C virus spread in rural areas of Egypt. J Hepatol. 2005;43(3):418-24.
31. Fernandez-Arcas N, Lopez-Siles J, Trapero S, Ferraro A, Ibanez A, Orihuela F, et al. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses. J Med Virol. 2006;78(11):1429-35.
32. Mohsen AH; Trent HCV Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut. 2001;48(5):707-13.
33. O'Brien SF, Yi QL, Fan W, Scalia V, Kleinman SH, Vamvakas EC. Current incidence and estimated residual risk of transfusiontransmitted infections in donations made to Canadian Blood Services. Transfusion. 2007;47(2):316-25.
34. Alberti A, Benvegnu L. Management of hepatitis C. J Hepatol. 2003;38 Suppl 1:S104-18.
35. Guerrini I, Gentili C, Guazzelli M. Alcohol consumption and heavy drinking: a survey in three Italian villages. Alcohol Alcohol. 2006;41(3):336-40.
36. Papatheodoridis GV, Goulis J, Christodoulou D, Manolakopoulos S, Raptopoulou M, Andrioti E, et al. High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity. Eur J Gastroenterol Hepatol. 2007;19(4):281-7.
37. Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol. 2006;101(1):76-82.
38. Ortiz V, Berenguer M, Rayon JM, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol. 2002;97(9):2408-14.
39. Ferenci P, Ferenci S, Datz C, Rezman I, Oberaigner W, Strauss R. Morbidity and mortality in paid Austrian plasma donors infected with hepatitis C at plasma donation in the 1970s. J Hepatol. 2007;47(1):31-6.
40. Alter MJ. Prevention of spread of hepatitis C. Hepatology. 2002;36(5 Suppl 1):S93-8.
41. Thomson BJ, Finch RG. Hepatitis C virus infection. Clin Microbiol Infect. 2005;11(2):86-94.